According to the revised Sapporo criteria for classification of the antiphospholipid syndrome, the disease is characterized by thrombosis, pregnancy complications, or both in patients with persistent antiphospholipid antibodies (lupus anticoagulant, anticardiolipin antibodies, or anti-β2GPI antibodies [2]. This evidence concerns the gene APOH and Venous thrombosis.